Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis
2013
International Union Against Tuberculosis and Lung Disease
Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis
2013
José A. Caminero, editor
with contributions from Armand Van Deun Paula I. Fujiwara Ignacio Monedero Chen-Yuan Chiang Anthony D. Harries Hans L. Rieder Einar Heldal Arnaud Trébucq Edith Alarcón Raimond Armengol Cécile Macé Christophe Perrin Riitta A. Dlodlo Gilles Cesari Donald A. Enarson
International Union Against Tuberculosis and Lung Disease
This publication was made possible thanks to the support of MISEREOR and the U.S. Centers for Disease Control and Prevention’s Coordinating Office for Global Health and National Center for HIV, Viral Hepatitis, STDs and TB Prevention
Editor
International Union Against Tuberculosis and Lung Disease (The Union) 68 boulevard St Michel, 75006 Paris, France Caminero JA, ed. Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis. Paris, France: International Union Against Tuberculosis and Lung Disease, 2013.
Suggested citation
First published online 22 March 2013; revised 6 May 2013.
© International Union Against Tuberculosis and Lung Disease (The Union) 68 boulevard St Michel, 75006 Paris, France March 2013 All rights reserved. No part of this publication may be reproduced without the permission of the authors and publisher. ISBN: 979-10-91287-03-6
Contents
Abbreviations 1 Justification for the Guidelines
Justification for the Guidelines: drug-resistant tuberculosis can be cured The challenge of a new epidemic and the lack of anti-tuberculosis medicines Lack of evidence in drug-resistant tuberculosis clinical and operational management Objectives of the Guidelines References
ix 1
1 2 4 4 5
2 Historical background and global epidemiology of Mycobacterium tuberculosis resistance
Historical background of anti-tuberculosis drug...